MACSF

COMMUNIQUÉS West-GlobeNewswire

Roxadustat China Phase 3 Trial for Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine (NEJM)
25/07/2019
-- One of Two Concurrent Publications of Roxadustat China Phase 3 Results in The New England Journal of Medicine -- SAN FRANCISCO, July 24, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced [...]
The New England Journal of Medicine (NEJM) Publishes Roxadustat China Phase 3 Results for the Treatment of Anemia in Chronic Kidney Disease Patients Receiving Dialysis
25/07/2019
-- One of Two Concurrent Publications of Roxadustat China Phase 3 Results in The New England Journal of Medicine -- SAN FRANCISCO, July 24, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the [...]
Helix Biopharma Corp. to Present at RHK Capital Conference in New York
24/07/2019
RICHMOND HILL, Ontario, July 24, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
American Pharmacies Uses FDS Analytics to Help Win $2 Fee Increase in New Mexico Medicaid
24/07/2019
FORT WORTH, Texas, July 24, 2019 (GLOBE NEWSWIRE) -- FDS Inc. today announced that New Mexico pharmacies scored an important political and financial win thanks to comprehensive analytics generated by American Pharmacies [...]
Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2019 Financial Results on August 1, 2019
24/07/2019
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT BURLINGAME, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company [...]
Alphatec Reports Second Quarter 2019 Financial Results and Corporate Highlights
24/07/2019
Full Year 2019 Revenue Guidance Increased Following 28% Q2 U.S. Revenue Growth CARLSBAD, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of [...]
SI-BONE to Present at the Canaccord Growth Conference on August 8, 2019
24/07/2019
SANTA CLARA, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management [...]
Aeglea BioTherapeutics Receives FDA Breakthrough Therapy Designation for Pegzilarginase for Treatment of Arginase 1 Deficiency
24/07/2019
Designation Follows Recently Reported ARG1-D Phase 1/2 Data Demonstrating Clinical Response in Patients Treated with Pegzilarginase AUSTIN, Texas, July 24, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: [...]
Chembio Diagnostics to Participate in the Canaccord Genuity Growth Conference
24/07/2019
MEDFORD, N.Y., July 24, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the company plans to participate in [...]
LeMaitre Vascular Announces Q2 2019 Financial Results
24/07/2019
BURLINGTON, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2019 results, provided guidance, and announced a $0. [...]
Align Technology Announces Second Quarter 2019 Financial Results
24/07/2019
Achieves 7 Millionth Invisalign Patient Milestone Q2 revenues up 22.5% year-over-year to a record $600.7 million Q2 Invisalign volume up 24.6% year-over-year to 377.1 thousand cases Q2 scanner and services revenues up [...]
Dynavax Technologies to Report Second Quarter 2019 Financial Results and Host Conference Call on August 7
24/07/2019
BERKELEY, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on developing novel vaccines, will report its second quarter 2019 [...]
Salarius Pharmaceuticals Successfully Monetizes Legacy Consumer Product
24/07/2019
Completes Sale of HOTSHOT HOUSTON, July 24, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancers, today announced it [...]
Collegium to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Provide Corporate Update
24/07/2019
STOUGHTON, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, August 7, 2019 at 4:30 [...]
MacroGenics Announces Date of Second Quarter 2019 Financial Results Conference Call
24/07/2019
Rockville, Md., July 24, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Cara Therapeutics Announces Proposed Offering of Common Stock
24/07/2019
STAMFORD, Conn., July 24, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
24/07/2019
Transaction to Create Nasdaq-listed Biotechnology Company Focused on Advancing NeuroBo’s Clinical-Stage Pipeline NeuroBo Poised to Advance Lead Drug Candidate into Phase 3 Trials for Neuropathic Pain Indications NeuroBo [...]
Cerner Reports Second Quarter 2019 Results
24/07/2019
All Key Metrics Within or Above Company Guidance Ranges KANSAS CITY, Mo., July 24, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced results for the 2019 second quarter that ended June 29, 2019 [...]
Genkyotex Conference Call for Post-Hoc Analysis of Setanaxib (GKT831) PBC Ph2 Trial and Business Update
24/07/2019
ARCHAMPS, France, July 24, 2019 (GLOBE NEWSWIRE) -- Genkyotex (Euronext Paris & Brussels: FR0013399474 – GKTX ) , a biopharmaceutical company and the leader in NOX therapies, will hold a conference call on July 25, [...]

Pages